What are the differences between motor and sensory neuropathies, and between small-fiber and large-fiber neuropathies, including their clinical features, diagnostic methods, and management?

Motor vs Sensory, Small vs Large Fiber Neuropathy: Detailed Clinical Information

Overview of Fiber Type Classification

Peripheral neuropathies are fundamentally classified by the type of nerve fiber affected—motor versus sensory, and within sensory fibers, small versus large—each producing distinct clinical syndromes that require different diagnostic approaches. 1

---

Large Fiber vs Small Fiber Neuropathy

Large Fiber Neuropathy

Large fiber neuropathies affect myelinated Aα/β fibers responsible for proprioception, vibration, light touch, and motor function. 1

Clinical Features:

• Sensory manifestations:

  • Loss of vibration sense (typically first sign)
  • Impaired proprioception leading to sensory ataxia
  • Reduced light touch perception
  • Numbness rather than pain
  • Positive Romberg sign

• Motor manifestations:

  • Distal muscle weakness and atrophy
  • Decreased or absent ankle reflexes (often earliest reflex loss)
  • Foot drop in advanced cases
  • Steppage gait

Diagnostic Approach:

• Nerve conduction studies (NCS) are abnormal and diagnostic 1
• Standard electrodiagnostic testing detects large fiber dysfunction with high sensitivity
• Clinical examination shows decreased vibration (128 Hz tuning fork) and proprioception
• Deep tendon reflexes are diminished or absent

---

Small Fiber Sensory Neuropathy (SFSN)

Small fiber neuropathy affects thinly myelinated Aδ fibers and unmyelinated C fibers, producing neuropathic pain and autonomic dysfunction while nerve conduction studies remain normal. 1, 2

Clinical Features:

• Sensory symptoms (length-dependent pattern):

  • Burning pain (most characteristic)
  • Dysesthesia and allodynia
  • Tingling and prickling sensations
  • Cold or heat sensations
  • Neuropathic itch
  • Pain is typically worse at night

• Autonomic features:

  • Abnormal sweating (hypohidrosis or hyperhidrosis)
  • Circulatory instability in feet
  • Erythromelalgia (red, hot, painful skin)
  • Gastrointestinal dysfunction
  • Urinary disturbances
  • Postural orthostatic tachycardia syndrome (POTS)
  • Cardiovascular instability 1, 3

Key Diagnostic Challenge:

Deep tendon reflexes and nerve conduction studies are normal in SFSN, creating a diagnostic gap that requires specialized testing. 1, 2

---

Diagnostic Testing Algorithm

For Large Fiber Neuropathy:

1. Nerve conduction studies (first-line, definitive)
2. Clinical examination: vibration, proprioception, reflexes
3. EMG if motor involvement suspected

For Small Fiber Neuropathy:

Skin biopsy with intraepidermal nerve fiber (IENF) density measurement is the validated diagnostic standard for SFSN. 1

Skin Biopsy Technique:

• 3 mm punch biopsy from distal leg
• Immunostaining with anti-PGP 9.5 antibodies
• IENF density quantification
• Diagnostic sensitivity: 80% 1, 2
• Specificity: 72-90% 1
• Safe, minimally invasive, validated technique 1

Autonomic Testing:

Autonomic testing should be considered for SFSN evaluation, particularly QSART (quantitative sudomotor axon reflex test) which documents small fiber sudomotor axon loss with high sensitivity. 1

• QSART sensitivity: 73-80% 1
• Specificity: 93-94% 1
• Heart rate variability testing for cardiovagal function
• Sympathetic skin response
• A battery of tests achieves highest diagnostic accuracy 1

Quantitative Sensory Testing (QST):

• Thermal threshold testing (warm/cold detection)
• Pain threshold assessment
• Sensitivity: 67% 1
• Less specific than skin biopsy but useful adjunct 4, 3

---

Motor vs Sensory Neuropathy Distinction

Motor-Predominant Neuropathy:

• Weakness and atrophy dominate
• Reflexes lost early
• Minimal sensory symptoms
• Examples: Guillain-Barré syndrome (acute), chronic inflammatory demyelinating polyneuropathy (CIDP), multifocal motor neuropathy

Sensory-Predominant Neuropathy:

• Sensory symptoms and signs dominate
• Motor function relatively preserved until late
• Can be large fiber (ataxia-predominant) or small fiber (pain-predominant) 5
• Examples: diabetic polyneuropathy, toxic neuropathies, hereditary sensory neuropathies

Mixed Sensorimotor Neuropathy:

• Both motor and sensory fibers affected
• Most common pattern in generalized polyneuropathies
• Diabetic polyneuropathy often evolves this way 1

---

Common Etiologies by Fiber Type

Small Fiber Neuropathy Causes:

• Diabetes/prediabetes (most common metabolic cause)
• Autoimmune disorders (Sjögren's syndrome)
• Sodium channelopathies (Nav1.7 mutations) found in ~30% of idiopathic cases 4, 6
• Vitamin B12 deficiency
• Toxic exposures (alcohol, chemotherapy)
• Infectious (HIV, hepatitis C)
• Idiopathic in 30-50% of cases 2, 3

Large Fiber Neuropathy Causes:

• Diabetes (advanced stages)
• Inflammatory demyelinating conditions (CIDP)
• Hereditary neuropathies (CMT)
• Nutritional deficiencies (B vitamins)
• Paraproteinemic neuropathies

---

Critical Diagnostic Pitfalls

1. Do not rely on nerve conduction studies alone for suspected neuropathy—they miss pure small fiber disease entirely 1

2. Normal NCS does not exclude neuropathy—proceed to skin biopsy and autonomic testing if clinical suspicion for SFSN exists 1, 2

3. Pain-predominant neuropathy with normal reflexes and NCS = small fiber neuropathy until proven otherwise 1, 5

4. Autonomic symptoms (sweating abnormalities, orthostasis) strongly suggest small fiber involvement 1

5. Burning pain in feet with normal examination and NCS requires skin biopsy, not dismissal as functional 1

---

Management Approach

Treatment Based on Etiology:

• Identify and treat underlying cause first 2, 3, 7
• Glucose control for diabetic neuropathy
• Immunotherapy for autoimmune causes 8
• Vitamin supplementation for deficiencies
• Toxin removal

Symptomatic Pain Management for SFSN:

First-line medications: 7

• Gabapentin or pregabalin
• Tricyclic antidepressants (amitriptyline, nortriptyline)

Second-line:

• Duloxetine or venlafaxine (SNRIs)
• Topical lidocaine patches
• Topical capsaicin

For Large Fiber Neuropathy:

• Physical therapy for weakness and gait instability
• Assistive devices for safety
• Treatment of underlying cause (immunotherapy for CIDP, etc.)

---

Key Takeaway for Clinical Practice

The fundamental distinction is that large fiber neuropathies are detected by standard nerve conduction studies and present with numbness, weakness, and ataxia, while small fiber neuropathies require skin biopsy or autonomic testing for diagnosis and present with burning pain and autonomic dysfunction despite normal nerve conduction studies. 1 This distinction drives the entire diagnostic and therapeutic approach.